Fact checked by Nick Blackmer The Food and Drug Administration (FDA) recently approved a new targeted chemotherapy drug for ...

Breast cancer, one of the most common cancers among women, could soon benefit from a new therapeutic approach. A new molecule ...

The effectiveness of the drug was evaluated in a clinical trial involving 866 people with advanced HR-positive, HER2-low breast cancer whose cancer progressed after hormone or targeted therapies ...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.

Trusted resource of information on Breast Cancer that includes articles, news, videos, animations, quizzes, health calculators and drugs.

A powerful new breast cancer drug has produced dramatic results. It greatly improves the chances of surviving the disease and could save thousands of lives. Experts have hailed the drug ...

Those ongoing studies seek to determine efficacy, and early testing showed trial subjects with metastatic breast cancer have tolerated the drug well with low-grade side effects. An earlier study ...

Despite significant therapeutic advances, breast ... drugs are better tolerated than chemotherapy, they still have side effects that diminish quality of life and can leave people at risk for ...

The National Institute for Health and Care Excellence (Nice) said the drug can be used for “treating HER2-negative locally advanced or metastatic breast cancer in adults with BRCA1 or BRCA2 ...

Those ongoing studies seek to determine efficacy, and early testing showed trial subjects with metastatic breast cancer have tolerated the drug well with low-grade side effects. An earlier study ...